Literature DB >> 20055712

Pseudomonas aeruginosa biofilm infections in cystic fibrosis: insights into pathogenic processes and treatment strategies.

Daniel J Hassett1, Thomas R Korfhagen, Randall T Irvin, Michael J Schurr, Karin Sauer, Gee W Lau, Mark D Sutton, Hongwei Yu, Niels Hoiby.   

Abstract

IMPORTANCE OF THE FIELD: CF airway mucus can be infected by opportunistic microorganisms, notably Pseudomonas aeruginosa. Once organisms are established as biofilms, even the most potent antibiotics have little effect on their viability, especially during late-stage chronic infections. Better understanding of the mechanisms used by P. aeruginosa to circumvent host defenses and therapeutic intervention strategies is critical for advancing novel treatment strategies. AREAS COVERED IN THIS REVIEW: Inflammatory injury in CF lung, role of neutrophils in pathogenesis, P. aeruginosa biofilms, mucoidy and its relationship with poor airway oxygenation, mechanisms by which P. aeruginosa biofilms in the CF airway can be killed. WHAT THE READER WILL GAIN: An understanding of the processes that P. aeruginosa undergoes during CF airway disease and clues to better treat such infections in future. TAKE HOME MESSAGE: The course of CF airway disease is a process involving host and microbial factors that often dictate frequency of pulmonary exacerbations, thus affecting the overall course. In the past decade significant discoveries have been made regarding the pathogenic processes used by P. aeruginosa to bypass the immune system. Many new and exciting features of P. aeruginosa now illuminate weaknesses in the organism that may render it susceptible to inexpensive compounds that force its own destruction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20055712     DOI: 10.1517/14728220903454988

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN: 1472-8222            Impact factor:   6.902


  46 in total

1.  Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells.

Authors:  Sangbrita S Chattoraj; Shyamala Ganesan; Andrew M Jones; Jennifer M Helm; Adam T Comstock; Rowland Bright-Thomas; John J LiPuma; Marc B Hershenson; Umadevi S Sajjan
Journal:  Thorax       Date:  2011-02-02       Impact factor: 9.139

Review 2.  The airway epithelium: soldier in the fight against respiratory viruses.

Authors:  Marjolaine Vareille; Elisabeth Kieninger; Michael R Edwards; Nicolas Regamey
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

3.  Pseudomonas aeruginosa interacts with epithelial cells rapidly forming aggregates that are internalized by a Lyn-dependent mechanism.

Authors:  Paola Lepanto; David M Bryant; Jéssica Rossello; Anirban Datta; Keith E Mostov; Arlinet Kierbel
Journal:  Cell Microbiol       Date:  2011-05-25       Impact factor: 3.715

4.  Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms.

Authors:  Marc B Habash; Mara C Goodyear; Amber J Park; Matthew D Surette; Emily C Vis; Robert J Harris; Cezar M Khursigara
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

5.  Effect of impaired twitching motility and biofilm dispersion on performance of Pseudomonas aeruginosa-powered microbial fuel cells.

Authors:  Devesh D Shreeram; Warunya Panmanee; Cameron T McDaniel; Susan Daniel; Dale W Schaefer; Daniel J Hassett
Journal:  J Ind Microbiol Biotechnol       Date:  2017-12-29       Impact factor: 3.346

Review 6.  Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Authors:  Anders Folkesson; Lars Jelsbak; Lei Yang; Helle Krogh Johansen; Oana Ciofu; Niels Høiby; Søren Molin
Journal:  Nat Rev Microbiol       Date:  2012-11-13       Impact factor: 60.633

Review 7.  Chronic obstructive pulmonary disease (COPD): evaluation from clinical, immunological and bacterial pathogenesis perspectives.

Authors:  Daniel J Hassett; Michael T Borchers; Ralph J Panos
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

8.  Genome-wide evaluation of the interplay between Caenorhabditis elegans and Yersinia pseudotuberculosis during in vivo biofilm formation.

Authors:  George W P Joshua; Steve Atkinson; Robert J Goldstone; Hannah L Patrick; Richard A Stabler; Joanne Purves; Miguel Cámara; Paul Williams; Brendan W Wren
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

9.  Gallium-Loaded Dissolvable Microfilm Constructs that Provide Sustained Release of Ga(3+) for Management of Biofilms.

Authors:  Maggie Herron; Michael J Schurr; Christopher J Murphy; Jonathan F McAnulty; Charles J Czuprynski; Nicholas L Abbott
Journal:  Adv Healthc Mater       Date:  2015-11-24       Impact factor: 9.933

10.  Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection.

Authors:  Rachel Y Chang; Jennifer Wong; Ash Mathai; Sandra Morales; Elizabeth Kutter; Warwick Britton; Jian Li; Hak-Kim Chan
Journal:  Eur J Pharm Biopharm       Date:  2017-09-07       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.